Effects of activating NK cell receptor expression and NK cell reconstitution on the outcomes of unrelated donor hematopoietic cell transplantation for hematologic malignancies

被引:32
|
作者
Triplett, B. M. [1 ]
Horwitz, E. M. [2 ]
Iyengar, R. [3 ]
Turner, V. [4 ]
Holladay, M. S. [3 ]
Gan, K. [3 ]
Behm, F. G. [5 ]
Leung, W. [3 ]
机构
[1] St Louis Univ, Div Hematol & Oncol, Dept Pediat,Bob Costas Canc Ctr, Cardinal Glennon Childrens Med Ctr, St Louis, MO 63104 USA
[2] Childrens Hosp Philadelphia, Div Oncol, Dept Pediat, Philadelphia, PA 19104 USA
[3] St Jude Childrens Hosp, Dept Oncol, Memphis, TN 38105 USA
[4] St Jude Childrens Hosp, Dept Pathol, Memphis, TN 38105 USA
[5] Univ Chicago, Dept Pathol, Chicago, IL 60637 USA
关键词
hematopoietic cell transplant; NK cell receptors; NK cell reconstitution post-HCT; BONE-MARROW-TRANSPLANTATION; NATURAL-KILLER-CELLS; IMMUNOGLOBULIN-LIKE RECEPTORS; VERSUS-HOST-DISEASE; ACUTE MYELOGENOUS LEUKEMIA; ACUTE MYELOID-LEUKEMIA; HLA CLASS-I; KIR GENES; T-CELLS; DNA METHYLATION;
D O I
10.1038/leu.2009.21
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Inhibitory NK cell receptors are recognized as important determinants of NK cell activity in hematopoietic cell transplantation (HCT). The role of activating receptors and their acquisition after HCT is less certain. Therefore, we comprehensively evaluated both inhibitory and activating receptors in 59 patients receiving unrelated donor HCT. NK cell numbers normalized quickly relative to B and T cells; however, the expression of both inhibitory and activating isoforms of killer immunoglobulin-like receptors (KIRs) was delayed. Most NK cells expressed an immature phenotype during the first 6 months post-HCT; however, we found high expression of activating NKp46 and NKp44 natural cytotoxicity receptors (NCRs), and cytotoxicity was preserved. Early reconstituting NK cells from unmanipulated grafts showed lower cytotoxicity than those from T-cell-depleted grafts. Differences in NK cell reconstitution had significant effects on clinical outcomes. Patients whose NK cells reconstituted earlier had better survival and lower relapse rates. The best survival group was recipients who possessed HLA-C2 but their donor lacked the cognate-activating KIR2DS1. Collectively, our data underscore the clinical relevance of reconstituting NK cells and their activating KIRs and NCRs. In addition to NK cell quantification and genotyping, comprehensive assessment of NK cell functions and phenotypes, including activating receptors, is essential. Leukemia (2009) 23, 1278-1287; doi: 10.1038/leu.2009.21; published online 12 February 2009
引用
下载
收藏
页码:1278 / 1287
页数:10
相关论文
共 50 条
  • [21] Delayed NK Cell Reconstitution and Reduced NK Activity Increased the Risks of CMV Disease in Allogeneic-Hematopoietic Stem Cell Transplantation
    Park, Ki Hyun
    Ryu, Ji Hyeong
    Bae, Hyunjoo
    Yun, Sojeong
    Jang, Joo Hee
    Han, Kyungja
    Cho, Byung Sik
    Kim, Hee-Je
    Lee, Hyeyoung
    Oh, Eun-Jee
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (10)
  • [22] Outcomes of patients undergoing third hematopoietic cell transplantation for hematologic malignancies
    Cox, Emily R.
    Summers, Corinne
    Milano, Filippo
    Dahlberg, Ann
    Bleakley, Marie
    Sandmaier, Brenda M.
    Thakar, Monica S.
    ANNALS OF HEMATOLOGY, 2024, 103 (09) : 3737 - 3743
  • [23] NK cell alloreactivity and allogeneic hematopoietic stem cell transplantation
    Ruggeri, Loredana
    Mancusi, Antonella
    Burchielli, Emanuela
    Capanni, Marusca
    Carotti, Alessandra
    Aloisi, Teresa
    Aversa, Franco
    Martelli, Massimo F.
    Velardi, Andrea
    BLOOD CELLS MOLECULES AND DISEASES, 2008, 40 (01) : 84 - 90
  • [24] Impact of Donor T Cells on NK Cell Development after Allogeneic Hematopoietic Cell Transplantation
    Alvarez, Maite
    Pierini, Antonio
    Baker, Jeanette
    Negrin, Robert
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2016, 22 (03) : S149 - S150
  • [25] Mismatched Related and Unrelated Donors for Allogeneic Hematopoietic Cell Transplantation for Adults with Hematologic Malignancies
    Eapen, Mary
    O'Donnell, Paul
    Brunstein, Claudio G.
    Wu, Juan
    Barowski, Kate
    Mendizabal, Adam
    Fuchs, Ephraim J.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2014, 20 (10) : 1485 - 1492
  • [26] NK Cell Therapeutics for Hematologic Malignancies: from Potential to Fruition
    Stephanie L. Fetzko
    Leander D. Timothy
    Robin Parihar
    Current Hematologic Malignancy Reports, 2023, 18 (6) : 264 - 272
  • [27] NK Cell Therapeutics for Hematologic Malignancies: from Potential to Fruition
    Fetzko, Stephanie L.
    Timothy, Leander D.
    Parihar, Robin
    CURRENT HEMATOLOGIC MALIGNANCY REPORTS, 2023, 18 (06) : 264 - 272
  • [28] Impact of NK cell alloreactivity on mismatched hematopoietic transplantation: An update on donor selection criteria and on transplantation outcomes.
    Velardi, A
    Ruggeri, L
    Capanni, M
    Urbani, E
    Tosti, A
    Mancusi, A
    Santucci, A
    Aversa, F
    Martelli, MF
    BLOOD, 2003, 102 (11) : 153A - 153A
  • [29] Advances in unrelated donor hematopoietic cell transplantation
    Anasetti, C
    HAEMATOLOGICA, 2003, 88 (03) : 246 - 249
  • [30] IMPACT OF DONOR NK CELL ALLORECOGNITION OF MISSING SELF ON HAPLOIDENTICAL HEMATOPOIETIC TRANSPLANTATION
    Velardi, Andrea
    CYTOMETRY PART A, 2010, 77A (02) : 151 - 152